• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左甲素通过递增比例程序减弱大鼠可卡因自身给药和可卡因辨别。

Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.

机构信息

Department of Biomedical Sciences, Marquette University, Milwaukee, WI 53201-1881, USA.

出版信息

Pharmacol Biochem Behav. 2010 Dec;97(2):310-6. doi: 10.1016/j.pbb.2010.08.016. Epub 2010 Sep 9.

DOI:10.1016/j.pbb.2010.08.016
PMID:20816889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2956862/
Abstract

Levo-tetrahydropalmatine (l-THP) is an alkaloid found in many traditional Chinese herbal preparations and has a unique pharmacological profile that includes dopamine receptor antagonism. Previously we demonstrated that l-THP attenuates fixed-ratio (FR) cocaine self-administration (SA) and cocaine-induced reinstatement in rats at doses that do not alter food-reinforced responding. This study examined the effects of l-THP on cocaine and food SA under progressive-ratio (PR) schedules of reinforcement and the discriminative stimulus effects of cocaine. In adult male Sprague-Dawley rats self-administering cocaine (0.5 or 1.0mg/kg/inf), l-THP significantly reduced breaking points at the 1.875, 3.75 and 7.5mg/kg doses. l-THP also reduced the breaking point and response rate for PR SA of sucrose-sweetened food pellets, although the decrease was significant only at the 7.5mg/kg l-THP dose. In rats trained to discriminate cocaine (10mg/kg, ip) from saline, l-THP (1.875, 3.75 and 7.5mg/kg) produced a rightward shift in the dose-response curve for cocaine generalization. During generalization testing, l-THP reduced response rate, but only at the 7.5mg/kg dose. l-THP also prevented substitution of the dopamine D2/D3 receptor agonist, (±) 7-OH-DPAT, for cocaine suggesting a potential role for antagonism of D2 and/or D3 receptors in the effects of l-THP. These data further demonstrate that l-THP attenuates the reinforcing and subjective effects of cocaine at doses that do not produce marked motor effects and provide additional evidence that l-THP may have utility for the management of cocaine addiction.

摘要

左甲素(l-THP)是一种存在于许多传统中药制剂中的生物碱,具有独特的药理学特性,包括多巴胺受体拮抗作用。我们之前的研究表明,l-THP 可在不改变食物强化反应的剂量下,减轻大鼠固定比例(FR)可卡因自我给药(SA)和可卡因诱导的复吸。本研究考察了 l-THP 在递增比例(PR)强化方案下对可卡因和食物 SA 的影响,以及可卡因的辨别刺激作用。在自行给予可卡因(0.5 或 1.0mg/kg/inf)的成年雄性 Sprague-Dawley 大鼠中,l-THP 显著降低了 1.875、3.75 和 7.5mg/kg 剂量的破码点。l-THP 还降低了蔗糖甜味食丸 PR SA 的破码点和反应率,尽管只有在 7.5mg/kg l-THP 剂量下才具有统计学意义。在训练大鼠区分可卡因(10mg/kg,ip)和盐水的研究中,l-THP(1.875、3.75 和 7.5mg/kg)使可卡因概括的剂量-反应曲线向右移动。在概括测试中,l-THP 降低了反应率,但仅在 7.5mg/kg 剂量下。l-THP 还阻止多巴胺 D2/D3 受体激动剂(±)7-OH-DPAT 替代可卡因,表明 l-THP 拮抗 D2 和/或 D3 受体在其作用中的潜在作用。这些数据进一步表明,l-THP 可在不产生明显运动效应的剂量下减轻可卡因的强化和主观效应,并提供了额外的证据表明,l-THP 可能对可卡因成瘾的管理有用。

相似文献

1
Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.左甲素通过递增比例程序减弱大鼠可卡因自身给药和可卡因辨别。
Pharmacol Biochem Behav. 2010 Dec;97(2):310-6. doi: 10.1016/j.pbb.2010.08.016. Epub 2010 Sep 9.
2
Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.左旋四氢巴马汀可减弱大鼠对可卡因的自我给药行为以及可卡因诱导的复吸。
Psychopharmacology (Berl). 2007 Jul;192(4):581-91. doi: 10.1007/s00213-007-0754-7. Epub 2007 Mar 15.
3
Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.口服左甲哌卡因可减轻可卡因、应激或与药物相关线索复燃已消除的可卡因觅药行为。
Drug Alcohol Depend. 2011 Jul 1;116(1-3):72-9. doi: 10.1016/j.drugalcdep.2010.11.023. Epub 2010 Dec 31.
4
Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.左旋四氢巴马汀抑制可卡因的奖赏效应:大鼠自我给药和脑刺激奖赏实验
Neuropharmacology. 2007 Nov;53(6):771-82. doi: 10.1016/j.neuropharm.2007.08.004. Epub 2007 Aug 15.
5
Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.对经训练能区分可卡因和生理盐水的大鼠体内D2和D3受体选择性配体的分析。
Pharmacol Biochem Behav. 1999 Oct;64(2):373-8. doi: 10.1016/s0091-3057(99)00064-7.
6
Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.多巴胺D2/D3受体调节可卡因对恒河猴的强化作用和辨别刺激效应。
Drug Alcohol Depend. 1999 Apr 1;54(2):97-110. doi: 10.1016/s0376-8716(98)00162-8.
7
Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.多巴胺间接激动剂、选择性D1样和D2样激动剂及拮抗剂对大鼠可卡因自我给药及食物维持反应的影响。
Neuropharmacology. 2004;47 Suppl 1:256-73. doi: 10.1016/j.neuropharm.2004.07.007.
8
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.多巴胺D2和D3偏好激动剂在大鼠中的辨别性刺激效应。
Psychopharmacology (Berl). 2009 Apr;203(2):317-27. doi: 10.1007/s00213-008-1323-4. Epub 2008 Sep 21.
9
The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.多巴胺D3受体拮抗剂PNU-99194A无法阻断(+)-7-羟基-DPAT替代右旋苯丙胺或可卡因。
Eur J Pharmacol. 1998 Oct 2;358(2):101-9. doi: 10.1016/s0014-2999(98)00582-2.
10
The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.多巴胺 D3 受体部分激动剂 CJB 090 抑制松鼠猴对可卡因的辨别性刺激,但不抑制其强化或启动效应。
Psychopharmacology (Berl). 2009 Sep;206(1):73-84. doi: 10.1007/s00213-009-1581-9. Epub 2009 Jun 10.

引用本文的文献

1
Natural Product-Inspired Dopamine Receptor Ligands.受天然产物启发的多巴胺受体配体。
J Med Chem. 2024 Aug 8;67(15):12463-12484. doi: 10.1021/acs.jmedchem.4c00537. Epub 2024 Jul 22.
2
Morphine Withdrawal-Induced Hyperalgesia in Models of Acute and Extended Withdrawal Is Attenuated by -Tetrahydropalmatine.-四氢巴马汀可减轻急性和延长撤药模型中吗啡撤药诱导的痛觉过敏。
Int J Mol Sci. 2023 May 17;24(10):8872. doi: 10.3390/ijms24108872.
3
Catalytic promiscuity of -methyltransferases from leading to the structural diversity of benzylisoquinoline alkaloids.来自[具体来源]的甲基转移酶的催化多效性导致苄基异喹啉生物碱的结构多样性。
Hortic Res. 2022 Jul 6;9:uhac152. doi: 10.1093/hr/uhac152. eCollection 2022.
4
Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine.海桐碱 4 减轻吗啡戒断的神经基础:左旋四氢巴马汀的作用。
Sci Rep. 2020 Dec 4;10(1):21275. doi: 10.1038/s41598-020-78083-x.
5
Role of natural products in mitigation of toxic effects of methamphetamine: A review of and studies.天然产物在减轻甲基苯丙胺毒性作用中的作用:对[具体研究1]和[具体研究2]的综述
Avicenna J Phytomed. 2020 Jul-Aug;10(4):334-351.
6
Pharmacokinetic Effects of -Tetrahydropalmatine on Ketamine in Rat Plasma by Ultraperformance Liquid Chromatography Tandem Mass Spectrometry.超高效液相色谱-串联质谱法研究-延胡索乙素对氯胺酮在大鼠血浆中药代动力学的影响。
Biomed Res Int. 2020 Jul 6;2020:9259683. doi: 10.1155/2020/9259683. eCollection 2020.
7
(-)-Stepholidine blocks expression, but not development, of cocaine conditioned place preference in rats.(-)-Stepholidine 阻断可卡因条件性位置偏爱大鼠的表达,但不影响其发展。
Neurosci Lett. 2020 Aug 24;734:135151. doi: 10.1016/j.neulet.2020.135151. Epub 2020 Jun 9.
8
(-)-Stepholidine reduces cue-induced reinstatement of cocaine seeking and cocaine self-administration in rats.(-)-石杉碱甲可减少大鼠线索诱导的可卡因觅药行为复发和可卡因自身给药。
Drug Alcohol Depend. 2018 Aug 1;189:49-54. doi: 10.1016/j.drugalcdep.2018.04.030. Epub 2018 May 31.
9
Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.Jitai 片对甲基苯丙胺诱导的多巴胺能神经毒性的保护和修复作用。
BMC Complement Altern Med. 2018 Feb 23;18(1):76. doi: 10.1186/s12906-018-2094-z.
10
l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats.左旋四氢巴马汀降低大鼠尼古丁自我给药及复吸行为。
BMC Pharmacol Toxicol. 2016 Nov 7;17(1):49. doi: 10.1186/s40360-016-0093-6.

本文引用的文献

1
Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats.左旋四氢巴马汀减轻大鼠中羟考酮诱导的条件性位置偏爱。
Eur J Pharmacol. 2009 Jan 14;602(2-3):321-7. doi: 10.1016/j.ejphar.2008.11.031. Epub 2008 Nov 25.
2
Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.左旋四氢巴马汀治疗可显著改善海洛因使用者的阿片类药物渴求并提高戒断率:一项初步研究。
Acta Pharmacol Sin. 2008 Jul;29(7):781-8. doi: 10.1111/j.1745-7254.2008.00817.x.
3
Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.左旋四氢巴马汀抑制可卡因的奖赏效应:大鼠自我给药和脑刺激奖赏实验
Neuropharmacology. 2007 Nov;53(6):771-82. doi: 10.1016/j.neuropharm.2007.08.004. Epub 2007 Aug 15.
4
Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.四氢原小檗碱类化合物研究的最新进展:抗伤害感受及药物成瘾机制
Cell Mol Neurobiol. 2008 Jun;28(4):491-9. doi: 10.1007/s10571-007-9179-4. Epub 2007 Aug 21.
5
Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.左旋四氢巴马汀可减弱大鼠对可卡因的自我给药行为以及可卡因诱导的复吸。
Psychopharmacology (Berl). 2007 Jul;192(4):581-91. doi: 10.1007/s00213-007-0754-7. Epub 2007 Mar 15.
6
Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.多巴胺D1样和D2样受体激动剂对恒河猴海洛因和可卡因自我给药行为的调节作用
J Pharmacol Exp Ther. 2007 Jun;321(3):1135-43. doi: 10.1124/jpet.107.120766. Epub 2007 Mar 9.
7
Brain pharmacokinetics and tissue distribution of tetrahydropalmatine enantiomers in rats after oral administration of the racemate.消旋四氢巴马汀口服给药后大鼠体内四氢巴马汀对映体的脑药代动力学及组织分布
Biopharm Drug Dispos. 2006 Apr;27(3):111-7. doi: 10.1002/bdd.489.
8
Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat.多巴胺D3和D4受体在大鼠可卡因辨别性刺激特性中的作用。
Methods Find Exp Clin Pharmacol. 2005 Nov;27(9):645-9. doi: 10.1358/mf.2005.27.9.939341.
9
The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.新型多巴胺D3受体拮抗剂NGB 2904可抑制可卡因的奖赏效应以及可卡因诱导的大鼠觅药行为复燃。
Neuropsychopharmacology. 2006 Jul;31(7):1393-405. doi: 10.1038/sj.npp.1300912. Epub 2005 Oct 5.
10
Medication development for addictive disorders: the state of the science.成瘾性疾病的药物研发:科学现状
Am J Psychiatry. 2005 Aug;162(8):1432-40. doi: 10.1176/appi.ajp.162.8.1432.